(Q53644849)
Statements
The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C. (English)
V H Hamilton
F E Racicot
H Zowall
L Coupal
S A Grover
1 April 1995
273
13
1032-1038